Injectable conductive and angiogenic hydrogels for chronic diabetic wound treatment

J Control Release. 2022 Apr:344:249-260. doi: 10.1016/j.jconrel.2022.03.014. Epub 2022 Mar 12.

Abstract

Chronic diabetic wounds are lack of angiogenesis and susceptible to bacterial infections due to their high sugar microenvironment, making them difficult to heal. Here, a conductive and intrinsically antibacterial hydrogel with pH responsiveness has been developed. This hydrogel has good mechanical properties, self-healing ability and biocompatibility, and can smartly release the pro-angiogenic drug, deferoxamine. Application of the hydrogel promotes the proliferation and migration of endothelial cells and enhances vascularization by upregulating the expression of hypoxia-inducible factor-1α and vascular endothelial growth factor. The hydrogel dressing combined with electrical stimulation improves angiogenesis and significantly accelerates the healing of infected diabetic wounds, which would lead to a promising therapeutic strategy.

Keywords: Chronic wounds; Conductive hydrogel; Electrical stimulation; Vascularization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus*
  • Endothelial Cells
  • Humans
  • Hydrogels* / chemistry
  • Vascular Endothelial Growth Factor A
  • Wound Healing

Substances

  • Hydrogels
  • Vascular Endothelial Growth Factor A